PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $314,000 | +163.9% | 147,992 | +288.9% | 0.03% | +142.9% |
| Q2 2016 | $119,000 | -79.4% | 38,056 | -78.1% | 0.01% | -93.5% |
| Q1 2016 | $579,000 | +24.5% | 173,813 | +32.3% | 0.22% | -2.7% |
| Q4 2015 | $465,000 | +114.3% | 131,402 | +204.2% | 0.22% | +276.3% |
| Q3 2015 | $217,000 | -25.9% | 43,200 | +13.5% | 0.06% | -61.7% |
| Q4 2014 | $293,000 | -85.0% | 38,055 | -85.5% | 0.15% | -69.1% |
| Q3 2014 | $1,954,000 | +327.6% | 261,620 | +453.9% | 0.50% | +286.8% |
| Q2 2014 | $457,000 | +54.9% | 47,229 | +32.9% | 0.13% | +34.4% |
| Q1 2014 | $295,000 | -48.1% | 35,525 | -47.2% | 0.10% | -10.3% |
| Q4 2013 | $568,000 | +314.6% | 67,330 | +279.6% | 0.11% | +197.2% |
| Q2 2013 | $137,000 | – | 17,739 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |